|The “forgotten joint” as the ultimate goal in joint arthroplasty: validation of a new patient-reported outcome measure|
H Behrend, K Giesinger, JM Giesinger, MS Kuster
The Journal of arthroplasty 27 (3), 430-436. e1, 2012
|Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust|
JM Giesinger, JM Kieffer, PM Fayers, M Groenvold, MA Petersen, ...
Journal of clinical epidemiology 69, 79-88, 2016
|Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?|
A Zabernigg, EM Gamper, JM Giesinger, G Rumpold, G Kemmler, ...
The oncologist 15 (8), 913-920, 2010
|Comparative responsiveness of outcome measures for total knee arthroplasty|
K Giesinger, DF Hamilton, B Jost, B Holzner, JM Giesinger
Osteoarthritis and cartilage 22 (2), 184-189, 2014
|Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review|
EM Gamper, A Zabernigg, LM Wintner, JM Giesinger, ...
Journal of pain and symptom management 44 (6), 880-895, 2012
|The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring|
B Holzner, JM Giesinger, J Pinggera, S Zugal, F Schöpf, ...
BMC medical informatics and decision making 12 (1), 1-11, 2012
|WOMAC, EQ-5D and knee society score thresholds for treatment success after total knee arthroplasty|
JM Giesinger, DF Hamilton, B Jost, H Behrend, K Giesinger
The Journal of arthroplasty 30 (12), 2154-2158, 2015
|Clinical performance of all-ceramic inlay and onlay restorations in posterior teeth|
US Beier, I Kapferer, D Burtscher, JM Giesinger, H Dumfahrt
Int J Prosthodont 25 (4), 395-402, 2012
|Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation|
S Pallua, J Giesinger, A Oberguggenberger, G Kemmler, D Nachbaur, ...
Bone marrow transplantation 45 (10), 1534-1539, 2010
|Age-and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients|
S Singer, S Kuhnt, R Zwerenz, K Eckert, D Hofmeister, A Dietz, ...
British journal of cancer 105 (3), 445-451, 2011
|Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research|
JM Giesinger, FLC Loth, NK Aaronson, JI Arraras, G Caocci, F Efficace, ...
Journal of clinical epidemiology 118, 1-8, 2020
|International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer|
S Wheelwright, AS Darlington, D Fitzsimmons, P Fayers, JI Arraras, ...
British journal of cancer 109 (4), 852-858, 2013
|Validation of the English language Forgotten Joint Score-12 as an outcome measure for total hip and knee arthroplasty in a British population|
DF Hamilton, FL Loth, JM Giesinger, K Giesinger, DJ MacDonald, ...
The bone & joint journal 99 (2), 218-224, 2017
|Quality of life trajectory in patients with advanced cancer during the last year of life|
JM Giesinger, LM Wintner, AS Oberguggenberger, EM Gamper, M Fiegl, ...
Journal of palliative medicine 14 (8), 904-912, 2011
|Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice|
A Erharter, J Giesinger, G Kemmler, G Schauer-Maurer, G Stockhammer, ...
Journal of pain and symptom management 39 (2), 219-229, 2010
|Quality of life during chemotherapy in lung cancer patients: results across different treatment lines|
LM Wintner, JM Giesinger, A Zabernigg, M Sztankay, V Meraner, G Pall, ...
British journal of cancer 109 (9), 2301-2308, 2013
|Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain|
JM Giesinger, W Kuijpers, T Young, KA Tomaszewski, E Friend, ...
Health and Quality of Life Outcomes 14 (1), 1-8, 2016
|Association of psychological status and patient-reported physical outcome measures in joint arthroplasty: a lack of divergent validity|
JM Giesinger, MS Kuster, H Behrend, K Giesinger
Health and quality of life outcomes 11 (1), 1-6, 2013
|Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)|
A Oberguggenberger, M Hubalek, M Sztankay, V Meraner, B Beer, ...
Breast cancer research and treatment 128 (2), 553-561, 2011
|The use of EORTC measures in daily clinical practice—a synopsis of a newly developed manual|
LM Wintner, M Sztankay, N Aaronson, A Bottomley, JM Giesinger, ...
European Journal of Cancer 68, 73-81, 2016